FIBREX Medical


COMPANY PROFILE


Investors

  Atlas Venture Euros


EMBL Ventures

Mulligan Biocapital AG
Fibrex Medical has raised 13 million Euros of venture capital funding so far from leading international venture investors. Major shareholders are Atlas Venture and Global Life Science Ventures (GLSV). Also participating in the financing were EMBL Ventures and Mulligan Biocapital AG.

[Additional resources >]


top

[printer-friendly version of this page]

©2005-2009 FIBREX Medical Inc.  •  info@fibrexmedical.com  •  Page last modified: 07.01.2009